EXTEND II: An Open-Label Phase III Multicentre Study to Evaluate Efficacy and Safety of Ranibizumab in Chinese Patients with Subfoveal Choroidal Neovascularization Secondary to Age-Related Macular Degeneration
Crossref DOI link: https://doi.org/10.1007/s40259-014-0106-1
Published Online: 2014-07-11
Published Print: 2014-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Zhao, Jialiang
Li, Xiaoxin
Tang, Shibo
Xu, Gezhi
Xu, Xun
Zhang, Feng
Zhang, Meixia
Shamsazar, Jila
Pilz, Stefan
Nieweg, Annette
Text and Data Mining valid from 2014-07-11